Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by johnnywickon Aug 02, 2017 6:46pm
56 Views
Post# 26540564

some psoriasis drug have over $5 billion in sales

some psoriasis drug have over $5 billion in sales
the established over priced psoriasis drug have over $5 billion in sales a year..

new psoriasis drugs usually starts like this...  after the fda approval and start selling

in the beginning.. sales usually around $100 million to few $hundred millions ...

in a year or 2... sales will climb to a $billion


I'm telling you now .. valeant's siliq going to be a huge winner later on ... and their psoriasis drug will become one of valeant's core assets.
<< Previous
Bullboard Posts
Next >>